Dominantly Inherited Alzheimer Network: facilitating research and clinical trials

被引:0
作者
Krista L Moulder
B Joy Snider
Susan L Mills
Virginia D Buckles
Anna M Santacruz
Randall J Bateman
John C Morris
机构
[1] Washington University School of Medicine,Department of Neurology
来源
Alzheimer's Research & Therapy | / 5卷
关键词
Mild Cognitive Impairment; Mutation Carrier; Secondary Prevention Trial; Asymptomatic Mutation Carrier; Clinical Trial Committee;
D O I
暂无
中图分类号
学科分类号
摘要
The Dominantly Inherited Alzheimer Network (DIAN) is an international registry of individuals at risk for developing autosomal dominant Alzheimer’s disease (AD). Its primary aims are to investigate the temporal ordering of AD pathophysiological changes that occur in asymptomatic mutation carriers and to identify those markers that herald the transition from cognitive normality to symptomatic AD. DIAN participants undergo longitudinal evaluations, including clinical and cognitive assessments and measurements of molecular and imaging AD biomarkers. This review details the unique attributes of DIAN as a model AD biomarker study and how it provides the infrastructure for innovative research projects, including clinical trials. The recent design and launch of the first anti-amyloid-beta secondary prevention trial in AD, led by the related DIAN Trials Unit, also are discussed.
引用
收藏
相关论文
共 445 条
  • [1] Hebert LE(2013)Alzheimer disease in the United States (2010–2050) estimated using the 2010 census Neurology 80 1778-1783
  • [2] Weuve J(2011)Alzheimer’s disease: the challenge of the second century Sci Transl Med 77 77sr1-1036
  • [3] Scherr PA(2011)Testing the right target and right drug at the right stage Sci Transl Med 3 111cm33-368
  • [4] Evans DA(2009)Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiol Aging 30 1026-1095
  • [5] Holtzman DM(1999)Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer’s disease Annals Neurol 45 358-1844
  • [6] Morris JC(2003)Neuropathology of cognitively normal elderly J Neuropathol Exp Neurol 62 1087-1402
  • [7] Goate AM(2006)Neuropathology of older persons without cognitive impairment from two community-based studies Neurology 66 1837-4500
  • [8] Sperling RA(2001)Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease Arch Neurol 58 1395-2129
  • [9] Jack CR(1996)Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease J Neurosci 16 4491-349
  • [10] Aisen PS(2013)Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology Neurology 80 2121-1475